[Skip to Content]
[Skip to Content Landing]
Comment & Response
September 2016

Intended Target of the Centers for Disease Control and Prevention Opioid Guidelines

Author Affiliations
  • 1Department of Biobehavioral Health Sciences, NewCourtland Center for Transitions and Health, University of Pennsylvania, Philadelphia
JAMA Oncol. 2016;2(9):1243. doi:10.1001/jamaoncol.2016.2185

To the Editor In their Editorial about the recently published Centers for Disease Control and Prevention (CDC) Guideline on opioid prescribing, Fisch and Chang state that, “Opioid use in cancer care and end-of-life care were excluded from the guidelines.”1(p862) It may stand corrected that the recent CDC opioid guideline only excluded cancer survivors in “active cancer treatment” from its scope.2 The CDC guideline is very much intended for cancer survivors who experience chronic cancer pain. Thus, this Editorial about safe, effective, and affordable care for cancer survivors with chronic unrelieved pain is relevant and timely.